# IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA

> **NCT02963649** · NA · COMPLETED · sponsor: **Medtronic Endovascular** · enrollment: 50 (actual)

## Conditions studied

- Critical Limb Ischemia
- Peripheral Arterial Disease

## Interventions

- **DEVICE:** DCB
- **DEVICE:** PTA

## Key facts

- **NCT ID:** NCT02963649
- **Lead sponsor:** Medtronic Endovascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-02
- **Primary completion:** 2019-10-07
- **Final completion:** 2023-12-21
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02963649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02963649, "IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02963649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*